EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

ShenQi ShenKang Granule Alleviates Chronic Kidney Disease by Inhibiting the PI3K/AKT/mTOR Pathway and Restoring Autophagy Flux and Mitochondrial Integrity

Chenhui Xia iD, Jiale Zhang iD, Huixi Chen, Shaofeng Zhou, Weimin Jiang, Huijuan Zheng iD, Zaoqiang Lin, Qinxiang Tan, Weiwei Sun

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s513824 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Chenhui Xia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Autophagy, TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalAutophagyTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktRenal Insufficiency, ChronicMitochondriaAnimalsRatsHumansPhosphatidylinositol 3-KinasesRats, Sprague-DawleyMaleSignal TransductionDose-Response Relationship, DrugCells, CulturedDisease Models, AnimalCell Survival

Stichwörter der Autor:innen

PI3K/AKT/mTOR pathwayShenqi Shenkang Granuleautophagychronic kidney diseasenetwork pharmacologyrenal fibrosis

Substanzen

Drugs, Chinese HerbalTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesMTOR protein, human

Autor:innen und Institutionen

  • Department of Nephrology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, People's Republic of China.
  • Department of Renal Research, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, People's Republic of China.
  • Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, People's Republic of China.
  • Department of Nephrology, Shenzhen Hospital Affiliated to Beijing University of Chinese Medicine, Shenzhen, Guangdong, People's Republic of China.

ORCID-Profile: Chenhui Xia, Jiale Zhang, Huijuan Zheng

Zitieren

APA

Xia, C., Zhang, J., Chen, H., Zhou, S., Jiang, W., Zheng, H., Lin, Z., Tan, Q., & Sun, W. (2025). ShenQi ShenKang Granule Alleviates Chronic Kidney Disease by Inhibiting the PI3K/AKT/mTOR Pathway and Restoring Autophagy Flux and Mitochondrial Integrity. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s513824

Vancouver

Xia C, Zhang J, Chen H, Zhou S, Jiang W, Zheng H, et al. ShenQi ShenKang Granule Alleviates Chronic Kidney Disease by Inhibiting the PI3K/AKT/mTOR Pathway and Restoring Autophagy Flux and Mitochondrial Integrity. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s513824

BibTeX
@article{Xia2025,
  author = {Xia, Chenhui and Zhang, Jiale and Chen, Huixi and Zhou, Shaofeng and Jiang, Weimin and Zheng, Huijuan and Lin, Zaoqiang and Tan, Qinxiang and Sun, Weiwei},
  title = {ShenQi ShenKang Granule Alleviates Chronic Kidney Disease by Inhibiting the PI3K/AKT/mTOR Pathway and Restoring Autophagy Flux and Mitochondrial Integrity},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s513824}
}
Kostenlos starten →